Plain-English translation of NCT07115563 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a targeted amino acid supplement designed to address specific nutritional deficiencies that commonly occur in people with Parkinson's disease. The supplement is a blend of six amino acids (Leucine, Tryptophan, Arginine, Taurine, Glutamate, and Tyrosine) chosen to meet the unique needs of your body when you have Parkinson's. Researchers will measure how the medication affects your amino acid levels, metabolism, muscle and body composition, physical abilities, and how you feel day-to-day.
People with Parkinson's disease often have imbalances in amino acids—the building blocks your body needs for muscle, movement, and overall health. This medication is designed to correct those specific deficiencies and support better physical function and quality of life in ways that standard treatments may not.
You likely qualify if…
You likely don't qualify if…
You would take a daily amino acid supplement (or a placebo control if randomly assigned to that group) and participate in study visits where researchers will take blood samples, measure your body composition and physical function, and ask you about your symptoms and quality of life. The study will track how the medication affects your amino acid levels, metabolism, muscle health, strength, and overall well-being over the course of the trial.
AI-generated summary from trial data · Jul 5, 2026 · Not medical advice
United States